Dedicated US diabetes "post" warranted:
This article was originally published in Clinica
Executive Summary
Some 12% of US federal healthcare spending goes towards diabetes treatment, says a National Changing Diabetes Program (NCDP) study, conducted by Mathematica Policy Research, that was profiled to the Congressional Diabetes Caucus on June 19. The sheer cost of the problem means that a government post should be created to oversee the spending on treatment and prevention among federal agencies. Using 2005 data, the study found that diabetics cost $80bn more to treat than non-diabetics - in a budget of $645bn that year. 18 out of the 21 federal agencies (ie not just HHS) have a budgetary impact on diabetes, it is claimed.